Inhibition of [3H]dopamine translocation and [3H]cocaine analog binding: A potential screening device for cocaine antagonists

Methods in Enzymology

Volumn 296, Issue , 1998, Pages 248-259

  Reith, Maarten E A ^a   Xu, Cen ^a   Carroll, F Ivy ^a   Chen, Nian Hang ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE DERIVATIVE; DOPAMINE; DOPAMINE TRANSPORTER; GB 12909; UNCLASSIFIED DRUG; VANOXERINE; (1R (EXO,EXO)) 3 (4 FLUOROPHENYL) 8 METHYL 8 AZABICYCLO(3.2.1)OCTANE 2 CARBOXYLIC ACID, METHYL ESTER; (1R-(EXO,EXO))-3-(4-FLUOROPHENYL)-8-METHYL-8- AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, METHYL ESTER; CARRIER PROTEIN; COCAINE; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; SODIUM; TRITIUM;

ANIMAL TISSUE; BINDING AFFINITY; BINDING SITE; DOPAMINE UPTAKE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REVIEW; ANIMAL; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; COMPUTER PROGRAM; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG DESIGN; METABOLISM; METHODOLOGY; RADIOASSAY; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANIMALIA;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL FRACTIONATION; CELL MEMBRANE; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG DESIGN; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RADIOLIGAND ASSAY; RATS; SODIUM; SOFTWARE; TRITIUM;

EID: 0031595288     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(98)96019-0     Document Type: Article

References (39)

1. M. W. Fischman and C.-E. Johanson, in "Pharmacological Aspects of Drug Dependence: Towards an Integrated Neurobehavioral Approach" (C. R. Schuster and M. J. Kuhar, Eds.), p. 159 (1996).
2. M. S. Briley, S. Z. Langer, R. Raisman, D. Sechter, and E. Zarifian, Science 209, 303 (1980).
3. N. Brunello, D. M. Chuang, and E. Costa, Science 215, 1112 (1982).
4. E. Costa, M. L. Barbaccia, O. Gandolfi, and D. M. Chuang, in "New Vistas in Depression" (S. Z. Langer, R. Takahashi, T. Segawa, and M. Briley, Eds.), p. 31. Pergamon Press, Oxford, 1985.
5. M. L. Barbaccia, O. Gandolfi, D. M. Chuang, and E. Costa, Proc. Natl. Acad. Sci. USA 80, 5134 (1983).
6. I. Hanbauer, L. T. Kennedy, M. C. Missale, and E. C. Bruckwick, in "New Vistas in Depression" (S. Z. Langer, R. Takahashi, T. Segawa, and M. Briley, Eds.), p. 41. Pergamon Press, Oxford, 1985.
7. M. E. A. Reith, NIDA Res. Monogr. 88, 23 (1988).
8. M. E. A. Reith, H. Sershen, and A. Lajtha, Neurochem. Res. 5, 1291 (1980).
9. C. R. Lee, A. M. Galzin, M. A. Taranger, and S. Z. Langer, Biochem. Pharmacol. 36, 945 (1987).
10. F. Artigas, E. Martinez, and A. Adell, Eur. J. Pharmacol. 181, 9 (1990).
11. E. Richelson and M. Pfenning, Eur. J. Pharmacol. 104, 277 (1984).
12. B. K. Krueger, J. Neurochem. 55, 260 (1990).
13. M. E. A. Reith, B. De Costa, K. C. Rice, and A. E. Jacobson, Eur. J. Pharmacol. 227, 417 (1992).
14. S. Saadouni, F. Refahi-Lyamani, J. Costentin, and J. J. Bonnet, Eur. J. Pharmacol. 268, 187 (1994).
15. J. S. McElvain and J. O. Schenk, Biochem. Pharmacol. 43, 2189 (1992).
16. J. J. Bonnet, S. Benmansour, J. Costentin, E. M. Parker, and L. X. Cubeddu, J. Pharmacol. Exp. Ther. 253, 1206 (1990).
17. K. M. Johnson, J. S. Bergmann, and A. P. Kozikowski, Eur. J. Pharmacol. 227, 411 (1992).
18. M. E. A. Reith, C. Xu, and L. L. Coffey, Biochem. Pharmacol. 52, 1435 (1996).
19. C. Xu, L. L. Coffey, and M. E. A. Reith, Naunyn-Schmiedeberg's Arch. Pharmacol. 355, 64 (1997).
20. K. J. Buck and S. G. Amara, Proc. Natl. Acad. Sci. USA 91, 12584 (1994).
21. S. Povlock and S. G. Amara, in "Neurotransmitter Transporters: Structure, Function, and Regulation" (M. E. A. Reith, Ed.), p. 1. Humana Press, Totowa, New Jersey, 1996.
22. S. Kitayama, S. Shimada, H. Xu, L. Markham, D. M. Donovan, and G. R. Uhl, Proc. Natl. Acad. Sci. USA 89, 7782 (1992).
23. F. I. Carroll, A. H. Lewin, and M. J. Kuhar, in "Neurotransmitter Transporters: Structure, Function, and Regulation" (M. E. A. Reith, Ed.), p. 263. Humana Press, Totowa, New Jersey, 1996.
24. M. H. Baumann, G. U. Char, B. R. De Costa, K. C. Rice, and R. B. Rothman, J. Pharmacol. Exp. Ther. 271, 1216 (1994).
25. A. N. Gifford, J. S. Bergmann, and K. M. Johnson, Drug Alcohol Depend. 32, 65 (1993).
26. D. Simoni, J. Stoelwinder, A. P. Kozikowski, K. M. Johnson, J. S. Bergmann, and R. G. Ball, J. Med. Chem. 36, 3975 (1993).
27. R. P. Shank, C. R. Schneider, and J. J. Tighe, J. Neurochem. 49, 381 (1987).
28. I. Zimanyi, A. Lajtha, and M. E. A. Reith, Naunyn Schmiedebergs Arch. Pharmacol. 340, 626 (1989).
29. S. C. Wall, R. B. Innis, and G. Rudnick, Mol. Pharmacol. 43, 264 (1993).
30. N. Amejdki-Chab, J. Costentin, and J. J. Bonnet, J. Neurochem. 58, 793 (1992).
31. R. B. Rothman, K. M. Becketts, L. R. Radesca, B. R. De Costa, K. C. Rice, F. I. Carroll, and C. M. Dersch, Life Sci. 53, PL267 (1993).
32. M. E. A. Reith and L. L. Coffey, J. Neurochem. 61, 167 (1993).
33. L. L. Coffey and M. E. A. Reith, J. Neurosci. Methods 51, 23 (1994).
34. D. O. Calligaro and M. E. Eldefrawi, Membr. Biochem. 7, 87 (1987).
35. C. Xu and M. E. A. Reith, J. Pharmacol. Exp. Ther. 282, 920 (1997).
36. C. Xu, L. L. Coffey, and M. E. A. Reith, Biochem. Pharmacol. 49, 339 (1995).
37. A. DeLean, P. J. Munson, and D. Rodbard, Am. J. Physiol. 235, E97 (1978).
38. P. J. Munson and D. Rodbard, Anal. Biochem. 107, 220 (1980).
39. F. I. Carroll, P. Kotian, A. Dehghani, J. L. Gray, M. A. Kuzemko, K. A. Parham, P. Abraham, A. H. Lewin, J. W. Boja, and M. J. Kuhar, J. Med. Chem. 38, 379 (1995).